The time of cure: hepatitis C treatment and the matter of reinfection among people who inject drugs

被引:2
|
作者
Rance, J. [1 ]
Grebely, J. [2 ]
Treloar, C. [1 ]
机构
[1] UNSW, Ctr Social Res Hlth, Sydney, Australia
[2] UNSW, Kirby Inst, Sydney, Australia
来源
HEALTH SOCIOLOGY REVIEW | 2024年 / 33卷 / 01期
基金
英国医学研究理事会;
关键词
Hepatitis C; cure; reinfection; time; futurology; new materialism;
D O I
10.1080/14461242.2024.2315031
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Australia has made considerable progress towards the public-health 'elimination' of the hepatitis C virus. Nonetheless, reinfection remains a key challenge, with little understanding regarding the lived complexities of post-cure life among people who inject drugs. Our analysis examines reinfection through the lens of 'time', a largely overlooked and under-utilised analytical concept within the field of hepatitis C. Drawing on qualitative data from a study examining treatment outcomes and reinfection, our analysis concentrates on three participant accounts or 'cases'. Working within a new materialist framework, we combine recent social science scholarship which, firstly, posits cure as a socio-material 'gathering', and secondly, proposes a 'futurology' of hepatitis C and its treatment. We found participant accounts troubled the neat binary of pre- and post-treatment life, instead detailing the challenges of remaining virologically safe while navigating complex, local life-worlds. Rather than a singular, post-treatment future instantiated by cure, participants described the fluid, emergent nature of what we might describe as 'lived' or 'embodied' time, including multiplicities of becoming in a perpetual present. We conclude that our understanding of reinfection needs to move beyond its current, narrow biomedical conception and organising temporal logic to honour and incorporate complexity in practice.
引用
收藏
页码:104 / 118
页数:15
相关论文
共 50 条
  • [31] Hepatitis C infection in people who inject drugs
    Azim, T.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 45 : 41 - 42
  • [32] SYMPOSIUM: ENHANCING HEPATITIS C CARE AMONG PEOPLE WHO INJECT DRUGS
    Hajarizadeh, Behzad
    Marshall, Alison D.
    Grebely, Jason
    Dore, Gregory J.
    Treloar, Carla
    Corry, Angela
    Hayllar, Jeremy
    Byrne, Jude
    DRUG AND ALCOHOL REVIEW, 2019, 38 : S8 - S9
  • [33] Dynamic modeling of hepatitis C transmission among people who inject drugs
    Stocks, Theresa
    Martin, Leah J.
    Kuhlmann-Berenzon, Sharon
    Britton, Tom
    EPIDEMICS, 2020, 30
  • [34] PREVALENCE AND PREDICTORS OF HEPATITIS C AMONG YOUNG PEOPLE WHO INJECT DRUGS
    Papanastasiou, Cerissa
    Dietze, Paul
    Higgs, Peter
    Jenkinson, Rebecca
    DRUG AND ALCOHOL REVIEW, 2011, 30 : 71 - 71
  • [35] Hepatitis C virus risk among young people who inject drugs
    Mateu-Gelabert, Pedro
    Sabounchi, Nasim S.
    Guarino, Honoria
    Ciervo, Courtney
    Joseph, Kellie
    Eckhardt, Benjamin J.
    Fong, Chunki
    Kapadia, Shashi N.
    Huang, Terry T. K.
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [36] Enhancing engagement in hepatitis C care among people who inject drugs
    Marshall, Alison D.
    Madden, Annie
    Treloar, Carla
    ADDICTION, 2019, 114 (12) : 2104 - 2106
  • [37] Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in India
    Clipman, Steven J.
    Mehta, Shruti H.
    Rodgers, Mary A.
    Duggal, Priya
    Srikrishnan, Aylur K.
    Saravanan, Shanmugam
    Balakrishnan, Pachamuthu
    Vasudevan, Canjeevaran K.
    Ray, Stuart C.
    Kumar, Muniratnam S.
    Quinn, Thomas C.
    Cloherty, Gavin A.
    Lucas, Gregory M.
    Solomon, Sunil S.
    HEPATOLOGY, 2021, 74 (04) : 1782 - 1794
  • [38] High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study
    Sacks-Davis, Rachel
    Aitken, Campbell K.
    Higgs, Peter
    Spelman, Tim
    Pedrana, Alisa E.
    Bowden, Scott
    Bharadwaj, Mandvi
    Nivarthi, Usha K.
    Suppiah, Vijayaprakash
    George, Jacob
    Grebely, Jason
    Drummer, Heidi E.
    Hellard, Margaret
    PLOS ONE, 2013, 8 (11):
  • [39] Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study
    Chacon, Fernando
    Morano, Luis
    Navarro, Jordi
    Granados, Rafael
    Llibre, Josep M.
    Ryan, Pablo
    Aldamiz-Echevarria, Teresa
    Carbonero, Luz Martin
    Puigvehi, Marc
    Clotet-Codina, Imma
    Sanchez-Vega, Nuria
    Vacas, Enrique
    Rincon, Oscar
    Berenguer, Juan
    Crespo, Javier
    Roncero, Carlos
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [40] Knowledge of, and attitude towards, the treatment of hepatitis C in people who inject drugs
    Roser, Patrik
    Brunstein, Mona
    Specka, Michael
    Timm, Joerg
    Kuehnhold, Stefan
    Schifano, Fabrizio
    Bonnet, Udo
    Scherbaum, Norbert
    HARM REDUCTION JOURNAL, 2024, 21 (01)